Skip to main content
OpenTrials

Clinical trial condition

Hemorrhagic Disorders

Explore clinical trials studying Hemorrhagic Disorders. Study availability and eligibility vary by location and protocol.

4,580 public trials 828 recruiting studies
Refine in advanced search Browse all conditions

Hemorrhagic Disorders trial results

Active, Not Recruiting

A 48-Month Study to Evaluate Long-Term Effectiveness of Elocta on Joint Health

NCT04293523

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • University Hospital Brno Brno, Czechia
  • University Hospital Ostrava Ostrava, Czechia
  • Dept. of Pediatric Haematology and Oncology, University Hospital Motol Prague, Czechia
  • Lastehaigla, Tallinn (Tallinn Children´s Hospital) Tallinn, Estonia
View all 53 locations
View Trial Details
Active, Not Recruiting

Effects of Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia (Paz)

NCT03850964

Conditions
Anemia, Cardiovascular Abnormalities, Cardiovascular Diseases, +22 more
Locations
  • University of California - Los Angeles Los Angeles, California, United States
  • University of Colorado Denver, Colorado, United States
  • Augusta University Augusta, Georgia, United States
  • John Hopkins University Baltimore, Maryland, United States
View Trial Details
Active, Not Recruiting

A Trial That Evaluates Disease Characteristics in Hemophilia B Adult Male Participants Receiving Prophylaxis With Standard of Care Factor IX Protein (FIX) Replacement Therapy

NCT05568459

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • University of Colorado Hemophilia and Thrombosis Center Aurora, Colorado, United States
  • Yale HTC New Haven, Connecticut, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • University of Florida Gainesville, Florida, United States
View all 17 locations
View Trial Details
Active, Not Recruiting

Study of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in Waldenstrom

NCT02952508

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Central Nervous System Lymphoma, +36 more
Locations
  • Cellectar Biosciences site Los Angeles, California, United States
  • Cellectar Biosciences site Redlands, California, United States
  • Cellectar Biosciences site Washington D.C., District of Columbia, United States
  • Cellectar Biosciences site Jacksonville, Florida, United States
View all 52 locations
View Trial Details
Active, Not Recruiting

A Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Autologous Stem Cell Transplant (ASCT) in Participants With Newly Diagnosed Multiple Myeloma

NCT05257083

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of Arkansas Little Rock, Arkansas, United States
  • City of Hope Duarte, California, United States
  • UC San Diego Health Moores Cancer Center San Diego, California, United States
  • University of California San Francisco (UCSF) San Francisco, California, United States
View all 106 locations
View Trial Details
Active, Not Recruiting

Assess Safety and Efficacy of VAD044 in HHT Patients

NCT05406362

Conditions
Arteriovenous Malformations, Cardiovascular Abnormalities, Cardiovascular Diseases, +11 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Universitair Ziekenhuis Gent Ghent, Belgium
  • Hospices Civils de Lyon Lyon, France
  • Ospedale Maggiore di Crema Crema, Italy
View Trial Details
Active, Not Recruiting

Minimal Residual Disease-based Strategy With T-Cell Redirector After Treatment With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (D-VRd) in Newly Diagnosed Multiple Myeloma

NCT06353022

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • CH de la Côte Basque Bayonne, France
  • CHU Caen Caen, France
  • CHRU DIjon Dijon, France
  • Chd Vendee La Roche-sur-Yon, France
View all 19 locations
View Trial Details

Related conditions